Terms: = Kidney tumors AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Diagnosis
20 results:
1. A case of esophageal squamous cell carcinoma accompanied by pancreatic and bile duct metastases: Successful treatment starts with an accurate diagnosis.
Ito Y; Ikura Y; Sawai H; Osuga T
J Cancer Res Ther; 2023 Oct; 19(7):2060-2063. PubMed ID: 38376319
[TBL] [Abstract] [Full Text] [Related]
2. Chromophobe-like carcinoma of the thymus: A clinicopathological and immunohistochemical correlation of 5 cases.
Weissferdt A; Moran CA
Pathol Res Pract; 2023 Aug; 248():154629. PubMed ID: 37348289
[TBL] [Abstract] [Full Text] [Related]
3. How I Diagnose Rosai-Dorfman Disease.
Ravindran A; Rech KL
Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
[TBL] [Abstract] [Full Text] [Related]
4. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
5. KLK4 Silencing Inhibits the Growth of Chromophobe Renal Cell Carcinoma through erk/AKT Signaling Pathway.
Fan B; Niu Y; Zhang A; Wei S; Ma Y; Su J; Ren Z
Kidney Blood Press Res; 2022; 47(12):702-710. PubMed ID: 36260980
[TBL] [Abstract] [Full Text] [Related]
6. Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the erk signaling pathway.
Xu Z; Chen S; Liu R; Chen H; Xu B; Xu W; Chen M
Mol Cancer; 2022 Jul; 21(1):146. PubMed ID: 35840930
[TBL] [Abstract] [Full Text] [Related]
7. Emerging role of LINC00461 in cancer.
Zhang Q; Zhong C; Shen J; Chen S; Jia Y; Duan S
Biomed Pharmacother; 2022 Aug; 152():113239. PubMed ID: 35679722
[TBL] [Abstract] [Full Text] [Related]
8. The molecular structure and role of LECT2 or CHM-II in arthritis, cancer, and other diseases.
Zhu S; Bennett S; Li Y; Liu M; Xu J
J Cell Physiol; 2022 Jan; 237(1):480-488. PubMed ID: 34550600
[TBL] [Abstract] [Full Text] [Related]
9. The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention.
Khan T; Kryza T; Lyons NJ; He Y; Hooper JD
Cancer Res; 2021 May; 81(9):2259-2269. PubMed ID: 33509939
[TBL] [Abstract] [Full Text] [Related]
10. P63-negative pulmonary NUT carcinoma arising in the elderly: a case report.
Numakura S; Saito K; Motoi N; Mori T; Saito Y; Yokote F; Kanamoto Y; Asami M; Sakai T; Yamauchi Y; Sakao Y; Uozaki H; Kawamura M
Diagn Pathol; 2020 Nov; 15(1):134. PubMed ID: 33176817
[TBL] [Abstract] [Full Text] [Related]
11. Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process: Clinicopathologic and Molecular Study of 7 Cases.
Agaimy A; Bonert M; Naqvi A; Wang C; Trpkov K; Dettmar P; Wintzer HO; Stoehr R; Hes O; Williamson SR; Gibson IW; Hartmann A
Am J Surg Pathol; 2020 Dec; 44(12):1658-1665. PubMed ID: 32910018
[TBL] [Abstract] [Full Text] [Related]
12. miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/erk/MMP2/MMP9 pathway.
Wang J; Wang C; Li Q; Guo C; Sun W; Zhao D; Jiang S; Hao L; Tian Y; Liu S; Sun MZ
Biomed Pharmacother; 2020 Jul; 127():110215. PubMed ID: 32413671
[TBL] [Abstract] [Full Text] [Related]
13. A first case report of primary epithelial myoepithelial carcinoma-like renal tumor showing a perivascular pseudorosette-like pattern: Description of morphologic, immunohistochemical, and genetic features.
Li Q; Mou Z; Yang K; Jiang H
Medicine (Baltimore); 2019 Sep; 98(39):e17245. PubMed ID: 31574838
[TBL] [Abstract] [Full Text] [Related]
14. Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases.
Ding Y; Wang C; Li X; Jiang Y; Mei P; Huang W; Song G; Wang J; Ping G; Hu R; Miao C; He X; Chen G; Li H; Zhu Y; Zhang Z
Diagn Pathol; 2018 Aug; 13(1):54. PubMed ID: 30111351
[TBL] [Abstract] [Full Text] [Related]
15. KIM-1 as a Blood-Based Marker for Early Detection of kidney Cancer: A Prospective Nested Case-Control Study.
Scelo G; Muller DC; Riboli E; Johansson M; Cross AJ; Vineis P; Tsilidis KK; Brennan P; Boeing H; Peeters PHM; Vermeulen RCH; Overvad K; Bueno-de-Mesquita HB; Severi G; Perduca V; Kvaskoff M; Trichopoulou A; La Vecchia C; Karakatsani A; Palli D; Sieri S; Panico S; Weiderpass E; Sandanger TM; Nøst TH; Agudo A; Quirós JR; Rodríguez-Barranco M; Chirlaque MD; Key TJ; Khanna P; Bonventre JV; Sabbisetti VS; Bhatt RS
Clin Cancer Res; 2018 Nov; 24(22):5594-5601. PubMed ID: 30037816
[No Abstract] [Full Text] [Related]
16. Lymphoepithelioma-like carcinoma of the upper urinary tract.
Lopez-Beltran A; Paner G; Blanca A; Montironi R; Tsuzuki T; Nagashima Y; Chuang SS; Win KT; Madruga L; Raspollini MR; Cheng L
Virchows Arch; 2017 Jun; 470(6):703-709. PubMed ID: 28455741
[TBL] [Abstract] [Full Text] [Related]
17. Expression and prognostic role of MEKK3 and perk in patients with renal clear cell carcinoma.
Chen Q; Lu HS; Gan MF; Chen LX; He K; Fan GM; Cao XQ
Asian Pac J Cancer Prev; 2015; 16(6):2495-9. PubMed ID: 25824786
[TBL] [Abstract] [Full Text] [Related]
18. Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential diagnosis of Invasive Urothelial Carcinoma.
Hoang LL; Tacha D; Bremer RE; Haas TS; Cheng L
Appl Immunohistochem Mol Morphol; 2015; 23(10):711-6. PubMed ID: 25611245
[TBL] [Abstract] [Full Text] [Related]
19. Oncocytoma-like renal tumor with transformation toward high-grade oncocytic carcinoma: a unique case with morphologic, immunohistochemical, and genomic characterization.
Sirintrapun SJ; Geisinger KR; Cimic A; Snow A; Hagenkord J; Monzon F; Legendre BL; Ghazalpour A; Bender RP; Gatalica Z
Medicine (Baltimore); 2014 Oct; 93(15):e81. PubMed ID: 25275525
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of tumor grade and stage with nuclear factor kappa b and p38 mitogene activated protein kinase expressions in renal cell cancer.
Ozbek E; Aliskan T; Otunctemur A; Calik G; Cakir S; Dursun M; Somay A
Arch Ital Urol Androl; 2012 Jun; 84(2):53-60. PubMed ID: 22908772
[TBL] [Abstract] [Full Text] [Related]
